DI/Pep1 is cleaved by MMP‐2 in the TME and transforms into aggregates with a high aspect ratio, thus controlling the drug release rate and prolonging the retention time of the drug in tumor tissues and enhancing site specificity and efficacy. This evidence concerns the gene MMP2 and neoplasm.